Chemomab Therapeutics (CMMB) has released an update.
Chemomab Therapeutics Ltd. invites shareholders to a Special General Meeting on November 18, 2024, to vote on a proposal to grant restricted share units to their CEO. Shareholders as of October 10, 2024, are eligible to vote and are encouraged to participate in person or by proxy to ensure their representation. The board unanimously recommends voting for the proposal, with voting instructions provided via Broadridge Financial Solutions or respective banks or brokers.
For further insights into CMMB stock, check out TipRanks’ Stock Analysis page.
